Hologic Inc.
Hologic Inc. Announces Results of Annual Meeting of Stockholders
Summary
Hologic Inc. held its Annual Meeting of Stockholders on March 7, 2024, where all nine director nominees were elected to the Board for a one-year term. Stockholders also provided advisory approval for the Company's executive compensation and ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending September 28, 2024.
Profitelligence Alerts
Get alerts for HOLX
Be first to know when Hologic Inc. files with the SEC.
Filing Categories
Advertisement
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Official SEC Documents
Advertisement